Our project team assessed the opportunities and hurdles for a novel mechanical thrombus ablation device across multiple indications.
Our client was facing changing market dynamics and needed to anticipate how growth and share for its product would evolve over the next three years.
Facing an investment decision, we helped our client validate the future outlook for vascular closure devices to guide funding of further product development.
Health Advances supported Audax from the initial diligence on Laborie through the ultimate sale in 2017.
